Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

DMK

DMK Pharmaceuticals (DMK)

DMK Pharmaceuticals Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:DMK
DataHoraFonteTítuloCódigoCompanhia
21/03/202415:23Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:DMKDMK Pharmaceuticals Corporation
07/02/202419:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DMKDMK Pharmaceuticals Corporation
06/02/202412:04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DMKDMK Pharmaceuticals Corporation
23/01/202419:23Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DMKDMK Pharmaceuticals Corporation
21/12/202310:15GlobeNewswire Inc.DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHINASDAQ:DMKDMK Pharmaceuticals Corporation
28/11/202310:05GlobeNewswire Inc.DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate UpdateNASDAQ:DMKDMK Pharmaceuticals Corporation
14/11/202309:30GlobeNewswire Inc.DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:DMKDMK Pharmaceuticals Corporation
13/11/202312:52GlobeNewswire Inc.DMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023NASDAQ:DMKDMK Pharmaceuticals Corporation
02/11/202317:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DMKDMK Pharmaceuticals Corporation
02/11/202317:31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:DMKDMK Pharmaceuticals Corporation
30/10/202308:30GlobeNewswire Inc.DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DMKDMK Pharmaceuticals Corporation
19/10/202317:05GlobeNewswire Inc.DMK Pharmaceuticals Restructures Executive Team to Support Next Phase of GrowthNASDAQ:DMKDMK Pharmaceuticals Corporation
17/10/202313:28Edgar (US Regulatory)Form PX14A6G - Notice of exempt solicitation submitted by non-managementNASDAQ:DMKDMK Pharmaceuticals Corporation
12/10/202317:22Edgar (US Regulatory)Form DEFC14A - Definitive proxy statement, contested solicitationsNASDAQ:DMKDMK Pharmaceuticals Corporation
02/10/202317:49Edgar (US Regulatory)Form PREC14A - Preliminary proxy statements, contested solicitationsNASDAQ:DMKDMK Pharmaceuticals Corporation
26/09/202309:37Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:DMKDMK Pharmaceuticals Corporation
07/09/202313:00GlobeNewswire Inc.Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic FocusNASDAQ:DMKDMK Pharmaceuticals Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:DMK

Seu Histórico Recente

Delayed Upgrade Clock